-
Location
-
One Letterman Drive, Building D, Suite D3 300, San Francisco, CA
-
Summary
-
The estimated value of insider holdings of Redmile Group, LLC is at least $448M dollars as of October 28, 2025. Redmile Group, LLC is the 10%+ Owner of ADC Therapeutics SA and owns shares of ADC Therapeutics SA (ADCT) stock worth about $140M. Redmile Group, LLC is the 10%+ Owner of RayzeBio, Inc. and owns shares of RayzeBio, Inc. stock worth about $116M. Redmile Group, LLC is the Director, 10%+ Owner of FATE THERAPEUTICS INC and owns shares of FATE THERAPEUTICS INC (FATE) stock worth about $45.7M. Redmile Group, LLC is the Director of Absci Corp and owns shares of Absci Corp (ABSI) stock worth about $41.1M. Redmile Group, LLC is the 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $31.3M. Redmile Group, LLC is the 10%+ Owner of Zymeworks Inc. and owns shares of Zymeworks Inc. (ZYME) stock worth about $30.6M. Redmile Group, LLC is the 10%+ Owner of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. (VERV) stock worth about $19.4M. Redmile Group, LLC is the 10%+ Owner of Adagio Therapeutics, Inc. and owns shares of Invivyd, Inc. (IVVD) stock worth about $13.4M. Redmile Group, LLC is the Director, 10%+ Owner of Shattuck Labs, Inc. and owns shares of Shattuck Labs, Inc. (STTK) stock worth about $6.92M. Redmile Group, LLC is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $3.36M.
-
Signature
-
By: /s/ Jeremy Green, Managing Member of Redmile Group, LLC